LFKRI Seminar Series

The 2021 LFKRI Seminar Series will be held via Zoom and in person at New York Blood Center Auditorium - 310 East 67th Street, NYC.

Register to attend

2021 Seminars

August 12, 2021 - 12 PM
“Stem-cell derived human lung buds”
Edwin Rosado-Olivieri, PhD 
Vice President, Rumi Viro 

Tuesday, August 24, 2021 - 11 AM
“The role of mDia2 in terminal maturation of red blood cells” 
Peng Ji, MD, PhD
Associate Professor, Department of Pathology, Northwestern University

Monday, September 13, 2021 - 11 AM
“Rare cells, big effect: tuft cells in pulmonary inflammation"

Huachao Huang, PhD (faculty recruit)
Associate Research Scientist, Columbia University Medical Center

Monday, September 20, 2021 -  11 AM - 1 PM
“NK cells: next generation cell therapies for cancer”
Katy Rezvani, MD, PhD
Professor, Sally Cooper Murray Endowed Chair in Cancer Research, Director of Translational Research, Section Chief of Cellular Therapy, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center 

“Cord Blood: Forerunners and New Horizons”
Elizabeth J. Shpall, MD
Professor, Howard and Lee Smith Chair in Cancer Research and Director, Cord Blood Bank and Cell Therapy Laboratory, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Tuesday, September 21, 2021 - 10 AM
"Development of a Notch-Mediated Cell Expansion and Differentiation Platform for the Generation of Universal Donor Cord Blood Derived Cell Therapies."

Colleen Delaney, MD
Chief Scientific Officer, Deverra Therapeutics, Inc., Clinical Professor, Division of Pediatric Hematology/Oncology, University of Washington/Seattle Children’s Hospital, Seattle

Monday, September 27, 2021 - 11 AM
"Inflammation and barrier crosstalk in the pathophysiology of respiratory infections“ 
M. Nadeem Khan, PhD (faculty recruit)
Assistant Professor, School of Medicine and Health Sciences, University of North Dakota 

Tuesday, October 5, 2021 - 11 AM
“Building tools to study normal and malignant hematopoietic precursors”
Jian Huang, MD, PhD (faculty recruit)
Associate Professor, Senior Scientist for Stem Cell Biology and Gene Engineering, Coriell Institute for Medical Research

Tuesday, October 12, 2021 - 11 AM
“ThPOKing Immune Cell Development and Function”
Jayati Basu, PhD, Research Assistant Professor, Fox Chase Cancer Center (faculty recruit)

Seminar Archive

  • + 2020 Seminars

    Thursday, April 23, 2020 – 12PM
    “Audaces fortuna adjuvant – Designing and using next generation adjuvants for vaccines and immunotherapies”

    Darrick Carter Ph.D.
    CEO, PAI Life Sciences Inc., Affiliate Professor, School of Medicine, Medical Genetics, University of Washington

    “Resolution of inflammation depends on Nuclear Receptor Nur77”
    Carlie JM de Vries, PhD 
    Professor and Chair Department of Medical Biochemistry, Amsterdam University Medical Center, The Netherlands

    “The role of mDia2 in terminal maturation of red blood cells”

    Peng Ji, MD, PhD
    Associate Professor, Department of Pathology, Director, Pathology Physician-Scientist Training Program, Northwestern University.

    Thursday, February 27, 2020 - 11AM
    “When Epigenetics Meet Metabolism in Hematopoiesis”

    Jian Xu, PhD
    Associate Professor, Children’s Research Institute, UT Southwestern Medical Center

    Thursday, February 13, 2020 - 11AM
    Beating swords into plowshares: the use of Fc receptor modification to develop a neutrophil extracellular trap targeted therapy for the treatment of sepsis”
    Kandace Gollomp, MD
    Instructor, Department of Pediatrics, Attending Physician, Division of Hematology, Children's Hospital of Philadelphia

  • + 2019 Seminars

    Thursday, December 19, 2019 - 11AM
    “Global Aspects in Cellular Therapy:  Standards, Science & Unproven Therapies”
    Joseph Schwartz, MD, MPH
    Director, Transfusion Medicine Services, Professor of Pathology & Cell Biology, Columbia University Medical Center

    Thursday, October 24, 2019 -- 11AM
    “Pathophysiological consequences of iron overload: lesson from a mouse model of type IV hereditary hemochromatosis

    Sandro Altamura, PhD
    Post-doctoral Fellow, University of Heidelberg and European Molecular Biology Laboratory (EMBL), Germany

    Wednesday, October 2, 2019 – 10AM
    From epidemiology to single-cell analysis: recent insights into malaria and sickle cell disease”
    Bronner Goncalves, MD, MPH, PhD
    Bioinformatics Scientist, National Institutes of Health and Medical Science & Computing, LLC

    Tuesday, September 24, 2019 – 11AM
    The 100,000 Genomes Project: New Genes for Rare Blood Diseases
    Willem H. Ouwehand, MD, PhD
    Professor of Experimental Hematology, University of Cambridge 

    Tuesday, August 20, 2019 – 11AM
    “Banking With Precision: Predicting Red Blood Cell Phenotypes from Next Generation Sequencing Data”
     Celina Montemayor, MD, PhD
     Staff Clinician, Assistant Clinical Investigator, Department of Transfusion Medicine, National Institutes of Health Clinical Center

    Tuesday, June 18, 2019 – 1PM
    “Characterizing Social Support Within the Sexual Networks of Gay Men: Implications for HIV Prevention Strategies”
    Jorge H. Soler, PhD, MPH
    Postdoctoral Fellow, HIV Center for Clinical and Behavioral Studies, Columbia University & New York State Psychiatric Institute

    WednesdayMay 8, 2019 1PM
    Old Pathways and New Players in Anemia of Chronic Disease and Diamond Blackfan Anemia
    Lionel Blanc, PhD
    Associate Professor of Molecular Medicine and Pediatrics, The Feinstein Institute for Medical Research, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

    FridayMarch22, 2019 - 11AM
    "SARS and MERS coronaviruses: cross-species transmission and vaccine design"
    Fang Li, PhD
    Associate Professor, Dept Veterinary andBiomedical SciencesUniversity of Minnesota Twin Cities

    Wednesday, January30, 2019 - 10AM
    Molecular Drivers of Platelet Production
    Joseph Italiano, PhD
    Associate Professor of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston Children’s Hospital

  • + 2018 Seminars

    Wednesday, December 12, 2018 - 10AM
    “Mitochondrial Dynamics and Intracellular Calcium Signaling Regulate Hematopoietic Stem Cell Function”

    Larry Luchsinger, PhD
    Associate Research Scientist, Department of Medicine, Columbia University Medical Center

    Thursday, November 1, 2018 - 10AM
    3D Bone Marrow modelling to document megakaryocyte functional regulation and diseases
    Alessandra Balduini, MD
    Associate Professor, University of Pavia, Italy; Research Associate Professor, Tufts University, Boston, MA

    Thursday, October 18, 2018 - 11AM
    “In vitro studies of erythropoiesis”
    Ashley Toye, PhD
    Principal Investigator, UK NHS-Blood & Transplant, and Senior Lecturer in Erythrocyte Biology, Department of Biochemistry, University of Bristol, UK

    Thursday, October 11, 2018 - 11AM
    “Thrombopoietic Agents in 2018: Ten Years Later”
    James Bussel, MD
    Professor Emeritus of Pediatrics, Weill Cornell Medical School, New York

    Thursday, October 4, 2018 - 11AM
    “Exploring the role of TAM (Tyro3_Axl_Mertk) receptors as a novel innate immune checkpoint in cancer immunotherapy" 
    Hind Medyouf, PhD
    Group Leader, Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany

    Thursday, September 13, 2018 - 11:30AM
    "Blood Center Considerations for Cellular Product Collections and Distribution"
    Robert J. Tressler PhD
    Vice President of Laboratories at San Diego Blood Bank

    Thursday, September 6, 2018 - 11AM
    “Modeling HIV pathogenesis, prevention and novel  therapies in humanized mice
    Ramesh Akkina, DVM, PhD
    Professor, Department of Microbiology, Immunology and Pathology, Colorado State University

    Wednesday, August 29, 2018 - 1PM
    "Setting up biobanks and translation research services in academia; experiences and challenges"
    Hassana Fathallah, PhD
    Director, Clinical Trials Scientific Affairs, ACM Global Laboratories, Rochester, New York

    WEDNESDAY, AUGUST 22, 2018 - 1PM
    “The role of CDMO's in the commercialization of cell therapy"
    Ruud Hulspas, PhD
    Founder, Cellular Technologies Bio-consulting, LLC, Rockville, MD 

    MONDAY, JULY 9, 2018 - 11AM
    "Pulmonary Inflammation in Sickle Cell Disease"
    Jeffrey A. Glassberg, M.D.
    Associate Professor of Hematology and Medical Oncology, and Emergency Medicine, Mount Sinai School of Medicine, New York

    THURSDAY, JUNE 14, 2018 - 11AM
    “Apheresis Collection for T cell Manufacturing: What’s in the bag and why do we care?”

    Andrew D. Fesnak, MD
    Assistant Professor, Director, Manufacturing, Clinical Cell and Vaccine Production Facility, University of Pennsylvania

    FRIDAY, APRIL 20, 2018 - 12PM
    "Patient Blood Management in Sickle Cell Disease"
    France Pirenne, MD, PhD
    Medical and Scientific Director, Etablissement Français du Sang, Créteil, Professor of Hematology, Institut Mondor de Recherche Biomédicale, lNSERM

    FRIDAY, MARCH 30, 2018 - 11AM 
    "Barriers and Facilitators to Potential Future Biomedical HIV Prevention Products in Transgender and Cisgender Women" 
    Christine Rael, PhD
    Postdoctoral Research Fellow, HIV Center for Clinical and Behavioral Studies, Columbia University

    THURSDAY, FEBRUARY 22, 2018 - 11AM
    "Role of Tissue Factor in Hemostasis, Thrombosis and Viral Infections"
    Nigel Mackman, PhD, FAHA
    John C. Parker
    Distinguished Professor of Medicine, Co-Director of the Thrombosis and Hemostasis Program, University of North Carolina at Chapel Hill

  • + 2017 Seminars

    MONDAY, DECEMBER 4, 2017 - 11AM
    "Armored Chimeric Antigen Receptor (CAR) T Cells for Solid Tumor Malignancies"

    Oladapo Yeku, MD, PhD
    Medical Oncology Fellow, Memorial Sloan Kettering Cancer Center

    THURSDAY, NOVEMBER 30, 2017 - 11AM
    "Type 1 Interferons Promote Alloimmune Responses to Transfused RBC Antigens"
    David Gibbs, MD, PhD
    Transfusion Medicine/Blood Bank Fellow, Department of Laboratory Medicine, Yale University

    TUESDAY, NOVEMBER 28, 2017 - 11AM
    "Stem Cell-Derived Megakaryocytes Tool for Translational Research and Source of Cellular Therapies"

    Camelia Iancu-Rubin, PhD
    Associate Professor, Scientific Director, Hematological Malignancies Tissue Bank, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

    MONDAY, NOVEMER 20, 2017 - 11AM
    "Investigations into the AML Cell Surfaceome"

    Fabiana Perna, MD, PhD
    Senior Research Scientist, Memorial Sloan Kettering Cancer Center, New York

    THURSDAY, November 16, 2017 - 11AM
    "Insights into Immune Defects in Rag-deficiency and Stem Cell Collections for Gene Therapy in Sickle Cell Anemia"

    John Manis, MD
    Associate Director of Transfusion Medicine, Boston Children's Hospital, Harvard Medical School

    THURSDAY, OCTOBER 12, 2017 - 11AM
    "Heterogeneity Assays and Platelet Lysate: Challenges and Chances for Stem Cell Therapies Development"

    Richard Schaefer, MD
    Head of Department Cell Therapeutics & Cell Processing, German Red Cross, Goethe-University Hospital, Frankfurt, Germany

    THURSDAY, SEPTEMBER 7, 2017 - 11AM
    "Exploring the Human Microbiome"

    Tao Ding, PhD
    Postdoctoral Researcher, Department of Biology, Center for Genomics and Systems Biology, New York University

    MONDAY, AUGUST 21, 2017 - 11AM
    "Inflammasomes and Danger Signals during Infection by Intracellular Pathogens"
    David M. Ojcius, PhD
    Professor and Chair, Department of Biomedical Sciences, University of the Pacific,Arthur A. Dugoni School of Dentistry

    MONDAY, JULY 24, 2017 - 2PM
    "Inflammatory Modulation of the Bone Marrow Hematopoietic Niche"
    Leslie E. Silberstein, MD
    Director, Joint Program in Transfusion Medicine, Professor, Harvard Medical School

    THURSDAY, JULY 20, 2017 - 11AM
    "Dickkopf-1: The Wnt Antagonist Becomes a Novel Immunomodulator"
    Wook-Jin Chae, PhD
    Associate Research Scientist, Department of Immunobiology, Yale University School of Medicine

    MONDAY, JULY 17, 2017 - 1PM
    “Making Platelets In Vitro from Pluripotent Stem Cells: Going Beyond Transfusion and Blood Clotting”
    Cedric Ghevaert, MD, PhD
    Consultant Hematologist, Senior Lecturer in Transfusion Medicine, Department of Hematology, University of Cambridge, UK

    THURSDAY, MAY 18, 2017 - 11AM
    “The Mechanism of Action of Anti-D in Preventing Hemolytic Disease of the Fetus and Newborn: What Do We Really Know?”
    Alan H. Lazarus, PhD
    Scientist, St. Michael's Hospital and Canadian Blood Services, Professor of Medicine, University of Toronto

    WEDNESDAY, APRIL 5, 2017 - 1PM
    “Genetics and Metabolomics of Blood Storage”
    James C. Zimring, MD, PhD
    Director and Chief Scientific Officer, BloodworksNW Research Institute, Professor, Department of Lab Medicine and Department of Medicine, University of Washington School of Medicine

    THURSDAY, MARCH 2, 2017 - 11AM
    “Insights into ZIKV Epidemiology, Diagnostics and Pathogenesis from Studies of Blood Donors and Recipients”

    Michael Busch, MD, PhD
    Director and VP, Research and Scientific Affairs, Blood Systems Research Institute

    THURSDAY, FEBRUARY 16, 2017 - 11AM
    “Engineering of Complex Tissues - New Possibilities for Drug Development and Regenerative Medicine”
    Jan Hansmann, PhD
    Group Leader, University Hospital of Würzburg, Fraunhofer Institute of Interfacial Engineering and Biotechnology

Want more information?

Email: lfkriseminar@nybc.org